title: Small HDL particles containing two apoA-I molecules are precursors in vivo to medium and large HDL particles containing three and four apoA-I molecules in nonhuman primates.
abstract: We hypothesized that small HDL particles, containing two apoA-I molecules but no apoA-II (LpAI), may be converted in vivo into medium and large HDL particles, containing three or four apoA-I molecules, respectively, and that more conversion will occur in animals with higher HDL concentrations. To test this possibility, kinetic studies of small LpAI were performed in African green monkeys with either high plasma HDL cholesterol concentrations (120 +/- 36 mg/dl, mean +/- SD, n = 3) or low plasma HDL cholesterol concentrations (40 +/- 13 mg/dl, n = 3). Tracer small LpAI was purified, without ultracentrifugation, by immunoaffinity and gel filtration. After injection, the specific activity of apoA-I in small, medium, and large HDL, consisting of both LpAI and LpAI:AII particles, was followed. A multicompartmental model was developed with the simultaneous analysis of urine and plasma turnover data for the kinetics of apoA-I in small, medium, and large HDL. These analyses indicated that small HDL is converted to either medium or large HDL with little or no interconversion of medium HDL and large HDL. Much of the metabolic conversion of small HDL occurs in a sequestered pool, effectively outside the circulating plasma, in a unidirectional manner before reentering the circulating plasma as medium or large HDL. The mean fractional catabolic rate of apoA-I in small, medium, and large HDL was not different comparing the high and low HDL group. In contrast, the mean production rate of apoA-I was greater in the high HDL group compared with the low HDL group. These data support the hypothesis that the plasma concentration of HDL is primarily a function of the rate of appearance of apoA-I in medium and large HDL.
authors.affiliation: Department of Pathology (Comparative Medicine), Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
authors.forename: P L
authors.initials: PL
authors.lastname: Colvin
authors.forename: E
authors.initials: E
authors.lastname: Moriguchi
authors.forename: P H
authors.initials: PH
authors.lastname: Barrett
authors.forename: J S
authors.initials: JS
authors.lastname: Parks
authors.forename: L L
authors.initials: LL
authors.lastname: Rudel
mesh_terms: D000818:Animals; D016632:Apolipoprotein A-I / Q000097:blood* / Q000378:metabolism; D002522:Chlorocebus aethiops; D002791:Cholesterol, Dietary; D008076:Cholesterol, HDL / Q000097:blood* / Q000737:chemistry*; D004036:Diet, Atherogenic; D004041:Dietary Fats; D007457:Iodine Radioisotopes; D007700:Kinetics; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D008956:Models, Chemical; D013961:Thyroid Gland / Q000378:metabolism
chemical_list: D016632:Apolipoprotein A-I; D002791:Cholesterol, Dietary; D008076:Cholesterol, HDL; D004041:Dietary Fats; D007457:Iodine Radioisotopes; D008077:Lipoproteins, LDL; C029310:lard